Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Intake process and ongoing support: Both Ro and Hers start with an online intake questionnaire reviewed by a licensed provider and include ongoing provider messaging
Fracture Risk Data from GLP1 Trials Several cardiovascular outcomes trials (CVOTs) have collected fracture data as secondary outcomes: Trials involving semaglutide and dulaglutide generally report fracture rates similar to placebo A few studies suggest a potential increase in non-vertebral fractures, though findings are inconsistent and often not statistically significant One important confounder is weight loss, which itself can lead to bone loss
doi: 10.1210/er.2007-0025 77 GreenCDMaceykaMCowartLASpiegelS
Lenton KJ, San AT, Therriault H, et al
US$ 22.90
US$ 24.29
US$ 28.38
US$ 20.72
